Li Su
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
- Oncology 50
- Lung Cancer Research Studies 23
-
- Respiratory Support and Mechanisms 18
- Lung Cancer Treatments and Mutations 10
- Co-authors
- David C. Christiani (117 shared papers)Geoffrey Liu (29 shared papers)Kofi Asomaning (24 shared papers)Ed Harlow (1 shared paper)Matthew Meyerson (1 shared paper)Li‐Huei Tsai (1 shared paper)G H Enders (1 shared paper)Rebecca Suk Heist (26 shared papers)
- Journals
- International Journal of Cancer (10 papers)Carcinogenesis (8 papers)PLoS ONE (8 papers)Cancer Epidemiology Biomarkers & Prevention (7 papers)Intensive Care Medicine (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Su
253 papers receiving 8.3k citations
Li Su's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.1k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.1k
- Genetics 1k
- Otorhinolaryngology 193
Countries citing papers authored by Li Su
This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).
Fields of papers citing papers by Li Su
This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 256 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A family of human cdc2‐related protein kinases. Hit paper breakdown → | 1992 | 813 |
| 2 | 2008 | 552 | |
| 3 | Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer Hit paper breakdown → | 2014 | 368 |
| 4 | 2010 | 204 | |
| 5 | 2014 | 179 | |
| 6 | 2007 | 175 | |
| 7 | 2014 | 171 | |
| 8 | 2010 | 144 | |
| 9 | 2012 | 117 | |
| 10 | 2008 | 107 | |
| 11 | 2009 | 101 | |
| 12 | 2010 | 97 | |
| 13 | 2004 | 93 | |
| 14 | 2018 | 92 | |
| 15 | 2009 | 90 | |
| 16 | Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. | 2001 | 88 |
| 17 | 2007 | 88 | |
| 18 | 2013 | 86 | |
| 19 | 2011 | 80 | |
| 20 | 2005 | 77 |
About Li Su
Li Su is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Cancer Research and Genetics, having authored 256 papers that have together received 8.5k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (32 papers), Lung Cancer Research Studies (23 papers), Esophageal Cancer Research and Treatment (18 papers), Respiratory Support and Mechanisms (18 papers), Epigenetics and DNA Methylation (14 papers), Atrial Fibrillation Management and Outcomes (13 papers), Heavy Metal Exposure and Toxicity (13 papers) and Lung Cancer Treatments and Mutations (10 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Genetics (1k citations) and Otorhinolaryngology (193 citations). Li Su has collaborated with scholars based in China, United States and Canada. Frequent co-authors include David C. Christiani, Geoffrey Liu, Kofi Asomaning, Ed Harlow, Matthew Meyerson, Li‐Huei Tsai, G H Enders, Rebecca Suk Heist, Rihong Zhai and John C. Wain. Their work appears in journals such as International Journal of Cancer, Carcinogenesis, PLoS ONE, Cancer Epidemiology Biomarkers & Prevention and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.